We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.75B
AUM Growth
+$227M
Cap. Flow
+$450M
Cap. Flow %
6.66%
Top 10 Hldgs %
24.03%
Holding
181
New
21
Increased
67
Reduced
21
Closed
25

Top Buys

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$76.7M
2
ZYME icon
Zymeworks
ZYME
+$56.8M
3
ENTG icon
Entegris
ENTG
+$55.4M
4
TSM icon
TSMC
TSM
+$52.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$49.2M

Top Sells

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$49.8M
2
W icon
Wayfair
W
+$45.9M
3
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$41.8M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$23.8M
5
CRWD icon
CrowdStrike
CRWD
+$23.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.16%
2 Technology 26.2%
3 Industrials 11.22%
4 Consumer Discretionary 7.43%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
1
DELISTED
Exact Sciences
EXAS
$229M 3.4%
1,740,000
– –
ASND icon
2
Ascendis Pharma A/S
ASND
$16.5B
$219M 3.24%
1,698,648
-5,500
-0.3% -$836K
FIVN icon
3
FIVE9
FIVN
$2.12B
$184M 2.73%
1,178,742
+9,474
+0.8% +$1.62M
TTD icon
4
Trade Desk
TTD
$8.59B
$179M 2.65%
2,743,250
+26,070
+1% +$2.01M
CRWD icon
5
CrowdStrike
CRWD
$189B
$163M 2.41%
3,565,140
-444,000
-11% -$23.5M
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$138M 2.04%
2,015,000
+231,239
+13% +$18.7M
TWLO icon
7
Twilio
TWLO
$29B
$134M 1.98%
392,090
+1,000
+0.3% +$375K
DT icon
8
Dynatrace
DT
$12.8B
$129M 1.91%
2,677,808
-36,200
-1% -$1.76M
ROP icon
9
Roper Technologies
ROP
$38.5B
$125M 1.86%
310,700
+4,500
+1% +$1.81M
LRCX icon
10
Lam Research
LRCX
$372B
$122M 1.8%
2,044,460
+3,650
+0.2% +$199K
MTD icon
11
Mettler-Toledo International
MTD
$27.9B
$119M 1.76%
103,000
– –
IDXX icon
12
Idexx Laboratories
IDXX
$44.1B
$117M 1.74%
240,000
– –
KRTX
13
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$117M 1.73%
971,077
+70,000
+8% +$7.93M
FVRR icon
14
Fiverr
FVRR
$330M
$115M 1.71%
531,562
+4,591
+0.9% +$1.13M
PRAX icon
15
Praxis Precision Medicines
PRAX
$8.58B
$109M 1.62%
234,205
– –
HUBS icon
16
HubSpot
HUBS
$11.9B
$108M 1.6%
236,987
– –
ASML icon
17
ASML
ASML
$634B
$106M 1.57%
172,000
– –
TT icon
18
Trane Technologies
TT
$97.3B
$103M 1.52%
620,800
+13,700
+2% +$2.12M
LOW icon
19
Lowe's Companies
LOW
$118B
$98.8M 1.46%
519,400
-6,900
-1% -$1.18M
XIFR
20
XPLR Infrastructure LP
XIFR
$1.12B
$98.3M 1.46%
1,349,100
+13,900
+1% +$1.07M
PLRX icon
21
Pliant Therapeutics
PLRX
$65.6M
$97.2M 1.44%
2,471,892
-366,233
-13% -$11.9M
GTM
22
ZoomInfo Technologies
GTM
$978M
$95.2M 1.41%
1,947,351
+48,500
+3% +$2.44M
DHI icon
23
D.R. Horton
DHI
$40.7B
$94.7M 1.4%
1,062,893
+303,093
+40% +$23.7M
ODFL icon
24
Old Dominion Freight Line
ODFL
$44.2B
$91.1M 1.35%
758,170
+30,170
+4% +$3.24M
WCN
25
Waste Connections
WCN
$41.9B
$86.8M 1.29%
804,000
– –
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Eventide Asset Management held 181 positions worth $6.75B, up 3.5% from $6.52B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $450M of net new capital in Q1 2021, opening 21 new positions and adding to 67 existing holdings. Its largest new stake was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $45.9M trimmed.

  • Eventide Asset Management's largest Q1 2021 buy was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.
  • Eventide Asset Management added most to Entegris in Q1 2021, an estimated $55.4M increase.
  • Eventide Asset Management's biggest Q1 2021 reduction was Wayfair, cutting an estimated $45.9M.
  • Eventide Asset Management fully exited Ecolab in Q1 2021, selling an estimated $49.8M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.75B portfolio in Q1 2021.
  • Eventide Asset Management opened 21 new positions and closed 25 in Q1 2021.
  • Eventide Asset Management's portfolio value rose 3.5% quarter-over-quarter to $6.75B.

Based on Eventide Asset Management's 13F filing for Q1 2021, filed 14 May 2021.